Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2995621000168113 | Citanest (prilocaine hydrochloride 100 mg / 5 mL) injection, 10 x 5 mL ampoules (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2995631000168111 | Citanest 2% (100 mg/5 mL) injection, 10 x 5 mL ampoules | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Citanest 2% (100 mg/5 mL) injection, 10 x 5 mL ampoules | Is a | trade product pack | true | Inferred relationship | Some | ||
| Citanest 2% (100 mg/5 mL) injection, 10 x 5 mL ampoules | Is a | prilocaine hydrochloride 2% (100 mg/5 mL) injection, 10 x 5 mL ampoules | true | Inferred relationship | Some | ||
| Citanest 2% (100 mg/5 mL) injection, 10 x 5 mL ampoules | has TPUU | Citanest 2% (100 mg/5 mL) injection, 5 mL ampoule | true | Inferred relationship | Some | 1 | |
| Citanest 2% (100 mg/5 mL) injection, 10 x 5 mL ampoules | has TP | Citanest | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Citanest 2% (100 mg/5 mL) injection, 10 x 5 mL ampoules | Is a | True | Citanest 2% (100 mg/5 mL) injection, 10 x 5 mL ampoules | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR